C
NexgenRx Inc. NEGXF
$0.1964 $0.00492.56% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 996.57% 7.43% 93.09% 212.21% 464.06%
Total Depreciation and Amortization -0.89% -7.48% 11.55% -5.41% -5.99%
Total Amortization of Deferred Charges -- -- -9.14% -- --
Total Other Non-Cash Items -172.33% -26.76% 336.55% -83.02% 278.65%
Change in Net Operating Assets -41.63% 65.53% -229.64% -158.76% 109.59%
Cash from Operations 0.94% 162.92% -41.12% -81.62% 62.09%
Capital Expenditure -729.78% -72.99% -136.78% 85.89% -435.71%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 6.62% -37.50% -- -- 26.59%
Cash from Investing -136.00% -48.33% -2,198.85% -24.18% 11.85%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -41.08% -64.25% -13.55% -53.18% -39.31%
Issuance of Common Stock -- -- -- 0.00% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 0.85% 6.12% 76.34% 1.63% 8.88%
Other Financing Activities -- -- -- -- --
Cash from Financing -1.50% -188.28% 78.22% -341.76% 7.07%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -47.41% 134.61% -123.15% -94.84% 8,305.13%